Faslodex 500mg Multiple Dose Tolerability Study in BC Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Fulvestrant
Sponsor: AstraZeneca